Home Newsfeeds Oppenheimer Downgrades CinCor Pharma to Perform

Oppenheimer Downgrades CinCor Pharma to Perform

Oppenheimer analyst Jay Olson downgrades CinCor Pharma (NASDAQ:CINC) from Outperform to Perform.

byBenzinga Newsdesk

November 29, 2022

1 minute read

Oppenheimer analyst Jay Olson downgrades CinCor Pharma (NASDAQ:CINC) from Outperform to Perform.

World’s Largest Apple iPhone Plant Hit With New Lockdowns In China: What You Need To Know

By Adam Eckert

November 2, 11:09 AM

China has ordered an industrial park that includes the world’s largest Apple Inc (NASDAQ: AAPL) iPhone assembly plant to enter a seven-day lockdown related to

AAPL

UBS Initiates Coverage On Vital Farms with Buy Rating, Announces Price Target of $16

By Benzinga Newsdesk

September 30, 6:37 AM

UBS analyst Cody Ross initiates coverage on Vital Farms (NASDAQ:VITL) with a Buy rating and announces Price Target of $16.

VITL

EXCLUSIVE: Adial Pharmaceuticals Announces Topline Results For ONWARD Phase 3 Trial For AD04 In Patients With Alcohol Use Disorder

By Benzinga Newsdesk

July 20, 6:45 AM

Charlottesville, VA – July 20, 2022 – Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing

ADIL

Netflix in Hot Water: Content Shortages, DVD Giveaway Confusion, and Residuals Controversy

By Mohit Manghnani

September 5, 11:57 AM

Today's top stories for Netflix Inc. (NASDAQ: NFLX) focus on the challenges and controversies the company is facing, from the impact of Hollywood strikes on content creation to legal questions surrounding a DVD giveaway, and the ongoing debate over fair residuals for actors.

NFLX

Oppenheimer Downgrades CinCor Pharma to Perform

Related Posts

World’s Largest Apple iPhone Plant Hit With New Lockdowns In China: What You Need To Know

UBS Initiates Coverage On Vital Farms with Buy Rating, Announces Price Target of $16

EXCLUSIVE: Adial Pharmaceuticals Announces Topline Results For ONWARD Phase 3 Trial For AD04 In Patients With Alcohol Use Disorder

Netflix in Hot Water: Content Shortages, DVD Giveaway Confusion, and Residuals Controversy